Vicki Jardine, VP of Clinical Development
Professional Overview
Vicki Jardine is an accomplished pharmaceutical executive with over a decade of experience leading global clinical development initiatives. As the Vice President of Clinical Development at ARTBIO, she leverages her deep expertise in oncology, ophthalmology, and neurology to drive the strategic advancement of the company's innovative drug pipeline.
Experience Summary
Current Role
As the VP of Clinical Development at ARTBIO, Vicki is responsible for overseeing all aspects of the company's clinical trials and regulatory submissions. She leads a team of clinical project managers and medical experts, ensuring the seamless execution of complex, multinational studies. Under her leadership, ARTBIO has successfully advanced several promising drug candidates through late-stage clinical development, demonstrating Vicki's ability to navigate the regulatory landscape and deliver results.
Career Progression
Prior to joining ARTBIO, Vicki held progressive leadership roles at Bayer, culminating in her position as Senior Clinical Development Leader. In this capacity, she spearheaded the development and implementation of innovative clinical trial strategies, contributing to the successful approval and commercialization of several Bayer products. Vicki's deep understanding of global regulatory requirements and her expertise in cross-functional collaboration have been instrumental in her career advancement.
Academic Background
Vicki holds a Medical Degree from the University of Cambridge and is a licensed physician in the United Kingdom. She has also completed postgraduate training in clinical research and drug development, further strengthening her expertise in the pharmaceutical industry.
Areas of Expertise
- Oncology, ophthalmology, and neurology drug development
- Global clinical trial design and execution
- Regulatory strategy and submissions
- Cross-functional team leadership and collaboration
- Data analysis and interpretation
- Project management and strategic planning
Professional Impact
Throughout her career, Vicki has made significant contributions to the advancement of pharmaceutical innovation. Her leadership in the development of several Bayer products has resulted in the availability of life-changing treatments for patients worldwide. At ARTBIO, Vicki is poised to continue her impact, driving the company's clinical pipeline forward and positioning it as a leader in the industry.
Conclusion
With her extensive experience, strong technical expertise, and proven track record of success, Vicki Jardine is a versatile and valuable asset to the pharmaceutical industry. As the VP of Clinical Development at ARTBIO, she is well-positioned to guide the company's clinical initiatives and contribute to its long-term growth and impact.
